Viewing nowShubastin Tablet 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 201607041 · Approved 2016.12.12 · Insurance code 658204730
Improvement of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular disease risk
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when not controlled by diet and exercise. It is also prescribed as an adjunct to diet for adolescents aged 10 years and older who have homozygous familial hypercholesterolemia or heterozygous familial hypercholesterolemia. This medication lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, and it also aids patients with dysbetalipoproteinemia. Specifically, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 years and women over 60 years who have risk factors for cardiovascular disease. Therefore, it is effectively used to control blood lipids and reduce the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to any ingredient of this drug, those with severely impaired liver function, those with muscle disorders, and those taking certain immunosuppressants should not take this medication. Additionally, patients with significantly impaired renal function and women who are pregnant or breastfeeding should not use this drug. The 40 mg dosage is contraindicated in patients at high risk of muscle disorders. When using this drug, liver function and muscle condition should be periodically checked. Patients who drink large amounts of alcohol or have a history of liver disease should be more cautious, and those with hypothyroidism or nephrotic syndrome should use it only after treating the underlying condition. Symptoms such as muscle pain, muscle weakness, or cramps should be reported immediately to healthcare professionals, and the use of this drug should be discontinued if necessary. This medication contains lactose, so patients with lactose intolerance should be careful. Also, this drug may interact with various medications, so if other medications are being taken, it is essential to consult a doctor or pharmacist. Specifically, when taken with some antiviral drugs, immunosuppressants, and fibrates, the risk of muscle toxicity may increase. Women of childbearing potential should use appropriate contraception before taking this drug, and it should not be taken during pregnancy or when planning to become pregnant. Women who are breastfeeding should also avoid taking this drug and consult a doctor if they need to take it. There is no specific antidote for overdose, so treatment should be based on symptoms and management should include liver function and muscle enzyme testing. This drug is known not to significantly impact driving or machinery operation; however, since dizziness may occur, caution is advised. Finally, this medication may present higher blood levels in Asians, so careful dosage determination is needed.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, peripheral neuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, fainting, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps ensure the drug's effectiveness is safely maintained.
Yellow round film-coated tablets
30 tablets (15 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.